These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29669274)

  • 1. Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire.
    Williams KL; Wang B; Arenz D; Williams JA; Dingens AS; Cortez V; Simonich CA; Rainwater S; Lehman DA; Lee KK; Overbaugh J
    Cell Rep; 2018 Apr; 23(3):682-691. PubMed ID: 29669274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection.
    Cortez V; Wang B; Dingens A; Chen MM; Ronen K; Georgiev IS; McClelland RS; Overbaugh J
    PLoS Pathog; 2015 Jul; 11(7):e1004973. PubMed ID: 26158467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.
    Chaillon A; Wagner GA; Hepler NL; Little SJ; Kosakovsky Pond SL; Caballero G; Pacold ME; Phung P; Wrin T; Richman DD; Wertheim JO; Smith DM
    J Virol; 2013 Dec; 87(23):12737-44. PubMed ID: 24049166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth.
    Sheward DJ; Marais J; Bekker V; Murrell B; Eren K; Bhiman JN; Nonyane M; Garrett N; Woodman ZL; Abdool Karim Q; Abdool Karim SS; Morris L; Moore PL; Williamson C
    Cell Host Microbe; 2018 Oct; 24(4):593-599.e3. PubMed ID: 30269971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.
    Blish CA; Dogan OC; Derby NR; Nguyen MA; Chohan B; Richardson BA; Overbaugh J
    J Virol; 2008 Dec; 82(24):12094-103. PubMed ID: 18842728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.
    Wagner GA; Landais E; Caballero G; Phung P; Kosakovsky Pond SL; Poignard P; Richman DD; Little SJ; Smith DM
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.
    Anthony C; York T; Bekker V; Matten D; Selhorst P; Ferreria RC; Garrett NJ; Karim SSA; Morris L; Wood NT; Moore PL; Williamson C
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.
    Cortez V; Odem-Davis K; McClelland RS; Jaoko W; Overbaugh J
    PLoS Pathog; 2012; 8(3):e1002611. PubMed ID: 22479183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.
    Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.
    Serwanga J; Ssemwanga D; Muganga M; Nakiboneka R; Nakubulwa S; Kiwuwa-Muyingo S; Morris L; Redd AD; Quinn TC; Kaleebu P;
    Vaccine; 2018 Jan; 36(4):578-586. PubMed ID: 29274699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional development of a V3/glycan-specific broadly neutralizing antibody isolated from a case of HIV superinfection.
    Shipley MM; Mangala Prasad V; Doepker LE; Dingens A; Ralph DK; Harkins E; Dhar A; Arenz D; Chohan V; Weight H; Mandaliya K; Bloom JD; Matsen FA; Lee KK; Overbaugh JM
    Elife; 2021 Jul; 10():. PubMed ID: 34263727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neutralizing Antibody Response to the HIV-1 Env Protein.
    Moore PL
    Curr HIV Res; 2018; 16(1):21-28. PubMed ID: 29173180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.
    Forthal DN; Landucci G; Chohan B; Richardson BA; McClelland RS; Jaoko W; Blish C; Overbaugh J
    J Acquir Immune Defic Syndr; 2013 May; 63(1):31-3. PubMed ID: 23344546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.
    Cohen YZ; Lorenzi JCC; Seaman MS; Nogueira L; Schoofs T; Krassnig L; Butler A; Millard K; Fitzsimons T; Daniell X; Dizon JP; Shimeliovich I; Montefiori DC; Caskey M; Nussenzweig MC
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
    Ssemwanga D; Doria-Rose NA; Redd AD; Shiakolas AR; Longosz AF; Nsubuga RN; Mayanja BN; Asiki G; Seeley J; Kamali A; Ransier A; Darko S; Walker MP; Bruno D; Martens C; Douek D; Porcella SF; Quinn TC; Mascola JR; Kaleebu P
    J Infect Dis; 2018 Apr; 217(10):1530-1534. PubMed ID: 29579256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection.
    Basu D; Kraft CS; Murphy MK; Campbell PJ; Yu T; Hraber PT; Irene C; Pinter A; Chomba E; Mulenga J; Kilembe W; Allen SA; Derdeyn CA; Hunter E
    Retrovirology; 2012 Sep; 9():76. PubMed ID: 22995123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity and Function of Maternal HIV-1-Specific Antibodies at the Time of Vertical Transmission.
    Doepker LE; Simonich CA; Ralph D; Shipley MM; Garrett M; Gobillot T; Vigdorovich V; Sather DN; Nduati R; Matsen FA; Overbaugh JM
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.
    Bhiman JN; Anthony C; Doria-Rose NA; Karimanzira O; Schramm CA; Khoza T; Kitchin D; Botha G; Gorman J; Garrett NJ; Abdool Karim SS; Shapiro L; Williamson C; Kwong PD; Mascola JR; Morris L; Moore PL
    Nat Med; 2015 Nov; 21(11):1332-6. PubMed ID: 26457756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.